Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Omorfi Kirurgi AB
AB
Active
Org 5593550659
Trastvägen 5
Hospital activities · NACE 8610
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 94K
+67% vs 2024
EBITDA margin
49.6%
+332% vs 2024
Equity ratio
75.2%
Financial strength
Net profit 2025
SEK 37K
+309% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 94K
+67%
EBITDA
SEK 47K
+332%
Net profit
SEK 37K
+309%
Total assets
SEK 186K
+16%
Equity
SEK 140K
+36%
Employees
1
—
Company information
Legal name
Omorfi Kirurgi AB
Org number
5593550659
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
20 december 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Kirurgi i öppenvård och slutenvård
Contact
Address
Trastvägen 5
Email
per.cachrimanidis@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Hospital activities
Companies in Helsingborg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
Revenue
0
139
56
94
Staff expenses
—
−1
−15
−5
EBITDA
−1
116
11
47
Depreciation & amort.
—
—
—
—
EBIT
−1
116
11
47
Net financials
—
—
1
−0
Profit before tax
−1
88
11
47
Tax
—
−18
−2
−10
Net profit
−1
70
9
37
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
Total assets
24
172
160
186
Equity
24
94
103
140
Long-term debt
—
—
—
—
Short-term debt
—
50
28
17
Total debt
—
50
28
17
Financial ratios
5-year trend
EBITDA margin
49.6%
This company
15.8%
Market median
+214% vs market
2022
2025
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
2022
2025
Return on equity
26.3%
This company
18.4%
Market median
+43% vs market
2022
2025
Net profit margin
39.1%
This company
8.1%
Market median
+383% vs market
2022
2025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2022
2025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-12-20 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
TV
Tania Veronica Johanna Altemani
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022
SP
Sokratis Per Cachrimanidis
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Omorfi Kirurgi AB also hold positions in
0
other companies.
Person
Role here
Other companies
Tania Veronica Johanna Altemani
Deputy Chief Executive Officer
0 companies
Sokratis Per Cachrimanidis
Chief Executive Officer
0 companies